Table 1

Patient age categories, m.3243A>G phenotype and cardiac findings

Patient noAge range
(years)
Blood; Urine; Muscle mtDNA
Heteroplasmy (%)
BMIDisease burden NMDASClinical featuresLVH pattern (cm)Lowest LVEF%ECG changesCardiac medications
140s21; 43;7327.533.5MELAS syndrome; SNHL; IDDM; myopathy; anaemia; CKD stage 4Concentric
(1.5)
50%–55%LVH and strainIrbesartan
Bisoprolol
220s33; 89; 8920.719.7Myoclonus; migraine; vaso-vagal syncope; ataxia; episodic vomiting; deafness; fatigue
(0.8)
50%LVH has cMRINormalNone
320s24; 80; NA24.31.0Asymptomatic
(0.8)
>55%NormalNone
440s34; 80; NA22.01.1Asymptomatic
(1.1)
50%–55%NormalBisoprolol
550s17; 75; 5022.835.2SNHL; CPEO; ataxia; myopathyConcentric
(1.3)
~55%LA-enlarged & LADRamipril
Bisoprolol
6*30s44; 86;8618.514.5Myopathy; fatigue; IDDM; mild SNHLConcentric
(1.5)
40%–45%Flat, inverted T-wavesPerindopril
Bisoprolol
7*30s43; 94; NA20.320.7Fatigue; mild SNHL; IDDMConcentric
(1.5)
>55%WPW & SVT (ablated); LVH & strain ECGLisinopril
Bisoprolol
850s17; 69; 6723.755.8SNHLs; IDDM; myopathy; glomerulonephritis; SA
(1.03)
25%–30%T-wave changes apicallyPerindopril
Bisoprolol
920s40; 71%; NA21.98.3Migraine; fatigue; intestinal pseudo-obstruction;Apex- only
(septum1.1)
>55%NormalNone
  • *Family history of sudden death.

  • BMI, body mass index; CKD, chronic kidney disease; CPEO, chronic progressive ophthalmoplegia; ECG, electrocardiogram; GFR, glomerular filtration rate; IDDM, insulin dependent diabetes mellitus; LAD, left axis deviation; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; MELAS, mitochondrial encephalopathy, lactic acidosis and stroke-like episodes; mtDNA, mitochondrial DNA; NMDAS, Newcastle Mitochondrial Disease Adult Scale; SA, sleep apnoea; SNHL, sensorineural hearing loss; SVT, supraventricular tachycardia; WPW, Wolff Parkinson White.